Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

Kourelis TV, Buadi FK, Kumar SK, et al.

Am J Hematol · 2016

Grade Bcohortn=262

Key Findings

  • 5-year PFS 58%, 5-year OS 78%
  • 30% experienced relapse/progression
  • Median time to relapse/progression 42 months
  • Complete hematologic response associated with PFS of 88%

Referenced in (1 disease)

ID: pmid-26669974DOI: 10.1002/ajh.24291PMID: 26669974